Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
@article{173168,
author = {Shrishti Garg and Mohammad Jalees and Himani Joshi},
title = {Human Metapneumovirus: A Hidden Threat in Respiratory Infections},
journal = {International Journal of Innovative Research in Technology},
year = {2025},
volume = {11},
number = {9},
pages = {2652-2659},
issn = {2349-6002},
url = {https://ijirt.org/article?manuscript=173168},
abstract = {Herbal Human Metapneumovirus (HMPV) is an under-recognized viral pathogen that contributes significantly to respiratory infections, particularly in vulnerable populations such as young children, the elderly, and immunocompromised individuals. Discovered in 2001, HMPV is a member of the Paramyxoviridae family and shares clinical features with other common respiratory viruses, including respiratory syncytial virus (RSV) and influenza, often complicating its diagnosis. Despite its importance in the etiology of lower respiratory tract infections, HMPV remains a hidden threat due to its clinical overlap with other viral infections and a lack of widespread diagnostic awareness. This review aims to examine the pathophysiology, epidemiology, clinical manifestations, and challenges in diagnosing HMPV, as well as current management strategies. While there is no specific antiviral treatment for HMPV, supportive care remains the cornerstone of management, highlighting the urgent need for targeted therapies and vaccines. Further research into HMPV’s clinical significance, diagnostic improvements, and the development of preventive measures is essential to mitigate its impact on public health.},
keywords = {Human Metapneumovirus (HMPV), Respiratory virus, HMPV symptoms, HMPV treatment, HMPV diagnosis, HMPV prevention, Pediatric respiratory infections, HMPV transmission, HMPV epidemiology, HMPV in adults, HMPV pathogenesis, HMPV and pneumonia, HMPV vaccination, HMPV and COPD (Chronic Obstructive Pulmonary Disease), HMPV complications.},
month = {February},
}
Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.
Join NowNational Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024
Submit inquiry